Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.
- Resource Type
- Article
- Source
- Signal Transduction & Targeted Therapy; 3/6/2024, Vol. 9 Issue 1, p1-10, 10p
- Subject
- Language
- ISSN
- 20959907